Compounds > cysteine

cysteine and Cleft Spine

cysteine has been researched along with Cleft Spine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kale, A; Kale, E1
Blom, HJ; den Heyer, M; Eskes, TK; Mariman, EC; Steegers-Theunissen, RP; Trijbels, FJ; van den Heuvel, LP; van der Put, NM1
Andria, G; Buoninconti, A; Capra, V; de Franchis, R; Del Gado, R; Mandato, C; Mastroiacovo, P; Pepe, A; Salvaggio, E; Sperandeo, MP1

Other Studies

3 other study(ies) available for cysteine and Cleft Spine

ArticleYear
The role of amino acids in spina bifida.
    Clinical and experimental obstetrics & gynecology, 2012, Volume: 39, Issue:3

    Topics: Adult; Alanine; Amino Acids; Amniocentesis; Amniotic Fluid; Cystathionine; Cysteine; Female; Gestational Age; Humans; Phenylalanine; Pregnancy; Pregnancy Trimester, Second; Spinal Dysraphism; Tryptophan; Tyrosine; Ultrasonography, Prenatal

2012
Decreased methylene tetrahydrofolate reductase activity due to the 677C-->T mutation in families with spina bifida offspring.
    Journal of molecular medicine (Berlin, Germany), 1996, Volume: 74, Issue:11

    Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; Aged; Child; Cysteine; Female; Folic Acid; Genetic Linkage; Genotype; Homocysteine; Homozygote; Humans; Lod Score; Lymphocytes; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Netherlands; Oxidoreductases; Point Mutation; Risk Factors; Spinal Dysraphism; Vitamin B 12

1996
The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy.
    Journal of medical genetics, 1998, Volume: 35, Issue:12

    Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; Case-Control Studies; Child; Cysteine; Genotype; Humans; Infant, Newborn; Italy; Meta-Analysis as Topic; Methylenetetrahydrofolate Dehydrogenase (NAD+); Methylenetetrahydrofolate Dehydrogenase (NADP); Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Prevalence; Risk Factors; Spinal Dysraphism; Threonine

1998